The store will not work correctly when cookies are disabled.
5-((2,5-Dioxopyrrolidin-1-yl)methyl)-N-hydroxy-[1,1'-biphenyl]-2-carboxamide
ID: ALA4776962
PubChem CID: 162643782
Max Phase: Preclinical
Molecular Formula: C18H16N2O4
Molecular Weight: 324.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NO)c1ccc(CN2C(=O)CCC2=O)cc1-c1ccccc1
Standard InChI: InChI=1S/C18H16N2O4/c21-16-8-9-17(22)20(16)11-12-6-7-14(18(23)19-24)15(10-12)13-4-2-1-3-5-13/h1-7,10,24H,8-9,11H2,(H,19,23)
Standard InChI Key: XJSCTVQZGQHBJQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
11.5887 -16.7231 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2951 -16.3124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0041 -16.7189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8449 -16.3942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5094 -17.5372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7106 -17.7096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3010 -17.0033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6721 -15.5917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0046 -17.5335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7127 -17.9399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4201 -17.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4150 -16.7078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7064 -16.3051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1296 -17.9347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1331 -18.7519 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8355 -17.5231 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5450 -17.9286 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1181 -16.2974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8287 -16.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5333 -16.2906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5284 -15.4725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8131 -15.0688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1115 -15.4836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1170 -18.0838 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
1 4 1 0
4 7 1 0
6 5 1 0
5 1 1 0
6 7 1 0
4 8 2 0
3 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 3 1 0
11 14 1 0
14 15 2 0
14 16 1 0
16 17 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
12 18 1 0
5 24 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.34 | Molecular Weight (Monoisotopic): 324.1110 | AlogP: 2.12 | #Rotatable Bonds: 4 |
Polar Surface Area: 86.71 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.94 | CX Basic pKa: ┄ | CX LogP: 1.45 | CX LogD: 1.44 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.51 | Np Likeness Score: -0.82 |
References
1. Mak JYW,Wu KC,Gupta PK,Barbero S,McLaughlin MG,Lucke AJ,Tng J,Lim J,Loh Z,Sweet MJ,Reid RC,Liu L,Fairlie DP. (2021) HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates., 64 (4.0): [PMID:33570940] [10.1021/acs.jmedchem.0c01967] |